Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000337417 | SCV000338500 | uncertain significance | not provided | 2016-01-26 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769837 | SCV000901263 | uncertain significance | Cardiomyopathy | 2017-02-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002411146 | SCV002675961 | likely benign | Cardiovascular phenotype | 2020-05-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002487185 | SCV002786873 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-10-17 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000337417 | SCV003819622 | uncertain significance | not provided | 2019-08-20 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000337417 | SCV005878766 | uncertain significance | not provided | 2024-01-09 | criteria provided, single submitter | clinical testing | The TTN c.107450C>T; p.Ser35817Leu variant (rs766440492; ClinVar Variation ID: 281477) is rare in the general population (<0.2% allele frequency in the Genome Aggregation Database) and has not been reported in the medical literature in association with dilated cardiomyopathy (DCM) or other TTN-related disease. The clinical relevance of rare missense variants in this gene, which are identified on average once per individual sequenced in affected populations (Herman 2012), is not well understood. Yet, evidence suggests that the vast majority of such missense variants do not contribute to the clinical outcome of DCM (Begay 2015). Thus, the clinical significance of the p.Ser35817Leu variant cannot be determined with certainty. References: Begay RL et al. Role of Titin Missense Variants in Dilated Cardiomyopathy. J Am Heart Assoc. 2015 Nov 13;4(11). PMID: 26567375. Herman DS et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012 Feb 16;366(7):619-28. PMID: 22335739. Linke WA and Hamdani N. Gigantic business: titin properties and function through thick and thin. Circ Res 2014; 114(6): 1052-1068. PMID: 24625729. |
Clinical Genetics, |
RCV000337417 | SCV001978973 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000337417 | SCV001979501 | uncertain significance | not provided | no assertion criteria provided | clinical testing |